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OVERVIEW — This background paper provides a review of mental health
coverage in the Medicare program. It examines the prevalence of mental
disorders among Medicare beneficiaries, treatment available through Medi-
care, and the cost of such treatment. A brief summary of relevant policy
issues is provided, including Medicare’s outpatient mental health limita-
tion and the potential effect of the prescription drug benefit on the provi-
sion of mental health services.
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Medicare and Mental Health: 
The Fundamentals
The Medicare prescription drug benefit has drawn attention to the mental 
health care needs of Medicare beneficiaries. This visibility is likely to be-
come more pronounced once the initial tab for psychotropic drugs under 
Part D is tallied. Press coverage highlighted the transition problems faced 
by mentally ill beneficiaries dually eligible for Medicare and Medicaid, 
as well as the high prices paid by Medicare drug plans for psychotropic 
drugs. Although psychotropic drugs are an important dimension of 
mental health treatment, providing appropriate mental health services 
to Medicare’s disabled and aged beneficiaries is a broader challenge than 
simply ensuring access to medications. Many mental health professionals 
contend that Medicare’s benefit structure is not optimally designed to sup-
port the kinds of mental health services demonstrated to be most effective 
for disabled and older Americans. 
As the prescription drug utilization and spending patterns of Medicare 
beneficiaries unfold over time, a broader examination of Medicare’s mental 
health coverage and payment policies may occur. When Medicare was 
first established in 1965, its benefit package was closely modeled after 
the typical commercial health insurance product of the time—a product 
that offered very limited coverage for mental health services. Traditional 
health insurance policies often singled out mental health services for more 
restricted benefits because of concerns that prevailing treatments were of 
questionable efficacy and that subjective diagnostic standards made the 
benefit particularly vulnerable to overuse. In creating the Medicare pro-
gram, few policymakers saw little impetus to depart from this conventional 
wisdom regarding the structure of mental health benefits.
Over the past 40 years, a number of changes have taken place in the financing 
and delivery of mental health services. Science has become increasingly ad-
ept at explaining how behavioral manifestations of mental illness are linked 
to biological mechanisms that disrupt brain and nervous system functions. 
As this evidence base has expanded, the diagnosis and treatment of mental 
health disorders has improved. Scientific and clinical advances, combined 
with legislative mandates and a growing understanding of how mental 
disorders influence general health status, have also increased insurers’ 
willingness to pay for mental health treatments. A variety of employer-
sponsored health insurance products have evolved to provide more 
extensive coverage for mental health while managing utilization in more 
sophisticated ways. Despite these changes, Medicare’s coverage for mental 
health services has evolved only modestly since the program’s inception. 
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Medicare’s benefit structure has, until recently, con-
cealed the impact of mental illness on beneficiary 
health, service use, and overall program costs. 
Mental disorders are at least as prevalent among 
beneficiaries as they are in the general population, 
yet Medicare spending on mental health has not 
matched that of other payers. Program policies that 
do not support preferred models of care have likely 
affected beneficiaries’ treatment and outcomes for 
some time. Outpatient mental health coverage 
restrictions, originally intended to minimize inap-
propriate service utilization, have the potential to 
foster an excessive reliance on pharmacological 
interventions and could contribute to higher utili-
zation of other, more expensive health care services, 
such as hospitalizations. 
New spending on psychotropic drugs and demo-
graphic changes in the beneficiary population will 
soon collide to raise the prominence of mental 
health issues within Medicare. The number of Medi-
care beneficiaries with mental illness is expected to 
grow substantially as a result of a variety of factors, 
including the large cohort of “baby boomers” ag-
ing into the program, longer life expectancies and 
the increasing prevalence of dementia and other 
cognitive disorders that come with advanced age, and an increase in the 
number of Americans qualifying for Social Security benefits (and thus for 
Medicare) on the basis of disability due to mental illnesses.1 At the same 
time, Part D–related expenses for psychotropic drugs are likely to more 
than double current mental health spending by Medicare. The convergence 
of these trends suggests a large increase in mental health spending over 
the next 15 years. 
Managing the cost and quality of care for chronic diseases in a largely 
fee-for-service context has long proved to be a difficult struggle for Medi-
care—and this struggle is abundantly apparent with respect to mental 
disorders. The diverse mix of services, providers, and care modalities 
inherent in mental health treatment, along with the cognitive limitations 
of people with mental disorders, combine to make utilization management 
and care coordination especially challenging. 
mental diSorderS and medicare BeneficiarieS
Medicare beneficiaries appear as likely to experience mental health 
problems as the general adult population.2 Over a 12-month period, ap-
proximately 26 percent of Medicare beneficiaries report having some type 
of mental disorder,3 compared to 26.2 percent of all noninstitutionalized 
a Word of caution
Prevalence estimates for mental disorders 
within the Medicare population are likely to 
be understated. Prevalence of mental disor-
ders in the general adult population has been 
determined through methodologically robust 
epidemiological studies that relied on standard 
clinical diagnostic criteria to identify persons 
with mental disorders and assessed the sever-
ity of confirmed cases. In contrast, prevalence 
estimates for the Medicare population rely 
solely on service utilization history to identify 
persons with mental health diagnoses. In reality, 
people who may not actually require treatment 
receive services—and people who need care do 
not receive it—yielding imprecise estimates of 
disease prevalence as a result of both over- and 
undercounting of cases. Rigorous studies of the 
prevalence of mental disorders in the general 
population indicate that undercounting domi-
nates, suggesting that prevalence estimates for 
Medicare beneficiaries are conservative.
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adults over the age of 18.4 These prevalence estimates reflect the inclusive 
definition of mental disorder used in the Diagnostic and Statistical Manual 
of Mental Disorders (DSM), which identifies a wide variety of mental health 
diagnoses, including mood disorders (such as depression), anxiety dis-
orders, psychoses, cognitive impairments (such as Alzheimer’s disease), 
and substance abuse. The severity of these disorders can vary significantly, 
both within and across diagnostic categories. 
As is the case in the general adult population, a relatively small proportion 
of all Medicare beneficiaries experience severe mental disorders (such as 
schizophrenia or major depression) that result in significant functional 
impairment. About 9 percent of Medicare beneficiaries have a severe 
mental disorder, compared to 6 percent of the general adult population 
(Figure 1, following page).5  However, the overall prevalence rate of severe 
illness among Medicare beneficiaries obscures important differences in 
the burden of disease in the aged beneficiary population relative to those 
who are eligible for Medicare due to disability.
Beneficiaries with disabilities account for a 
relatively small proportion of all Medicare ben-
eficiaries, but this group has grown rapidly in 
recent years. The number of disabled Medicare 
beneficiaries more than doubled between 1990 and 
2005, with increasing numbers of disability awards 
due to mental illness being a major source of this 
growth. Disabled beneficiaries currently represent 
nearly 14 percent of all persons who are covered by 
Medicare. Growth in the number of beneficiaries 
with disabilities has been attributed to a number 
of policy changes rather than changes in underly-
ing disease prevalence. Policy changes clarified 
Social Security’s disability determination criteria, 
resulting in more approvals and fewer termina-
tions. Several of these changes focused specifically 
on liberalizing the disability determinations for 
mental disorders, such as tying determinations 
to functionality assessments and mandating re-
view by a specialty mental health provider in all 
appealed denials. People judged to be disabled 
and awarded Social Security Disability Insurance 
benefits are eligible for Medicare on the basis of 
their disability.
Total SSDI
Awards
Mental Disorder
Awards
Years: 1960 – 2004*
0
200,000
400,000
600,000
800,000
*Data were not available for the years 1964, 1965, 1966, 1974, 1979, 
and 1980. The trends are shown as continuous, but the data have been 
extrapolated.
Source: Social Security Administration, “Annual Statistical Report on 
the Social Security Disability Insurance Program, 2004,” March 2006, 
p. 98; available at www.ssa.gov/policy/docs/statcomps/di_asr/2004/index.
html#editions.
Growth in disability awards related to mental disorders
SSdi awards to disabled Workers
Background paper
november 27, 2006
national health policy forum  |  www.nhpf.org 6
mental disorders among disabled Beneficiaries
Severe mental illness is highly prevalent among Medicare beneficiaries 
under the age of 65 who qualify for Medicare because of a disability. Ap-
proximately 37 percent of disabled Medicare beneficiaries have a severe 
mental disorder,6 compared to only 4 percent of aged beneficiaries.7 The 
high rate of mental disorders in the disabled Medicare population is pri-
marily driven by the large proportion of disabled beneficiaries who qualify 
for Medicare because of a long-lasting and disabling mental illness. Since 
1987, both the number and proportion of disability awards due to mental 
illness have increased dramatically. Mental disorders were the leading 
reason disabled workers received Social Security Disability Insurance 
(SSDI) in 2004.8 
People who qualify for Medicare based on a physical disability may also 
have comorbid, potentially severe, mental disorders, and the prevalence of 
all types of mental disorders appears high for this population. An estimated 
59 percent of all disabled beneficiaries have some type of mental disorder, 
compared to 21 percent of aged beneficiaries.9 The rate of severe mental 
illness among the physically disabled is not well documented.
Even with Medicare’s limited benefits, care for disabled beneficiaries with 
mental disorders is costly. Excluding persons with end-stage renal disease, 
fiGure 1
prevalence of mental disorders
 
 
Sources: William E. Narrow et al., “Revised Prevalence Estimates of Mental Disorders in the United 
States,” Archives of General Psychiatry, 59, Feb 2002; Ronald C. Kessler et al., “Prevalence and 
Treatment of Mental Disorders, 1990 to 2003,” New England Journal of Medicine, 352, no. 24 (June 
15, 2005), pp. 2515–2523; Henry J. Kaiser Family Foundation, Medicare Chartbook (Menlo Park, CA: 
Henry J. Kaiser Family Foundation, 3rd ed., Summer 2005), available at www.kff.org/medicare/upload/
Medicare-Chart-Book-3rd-Edition-Summer-2005-Report.pdf.; Ronald C. Kessler et al., “Estimating the 
Prevalence and Correlates of SMI in Community Epidemiological Studies,” chap. 12 in Mental Health, 
United States, 2002, Ronald W. Manderscheid and Marilyn J. Henderson, (Eds.), DHHS Publication 
No. SMA04-3938 (Rockville, MD: U.S. Department of Health and Human Services, 2002), available at 
http://mentalhealth.samhsa.gov/publications/allpubs/sma04-3938/Chapter12.asp; and Sandra M. Foote 
and Christopher Hogan, “Disability Profile And Health Care Costs Of Medicare Beneficiaries Under 
Age Sixty-Five,” Health Affairs, 20, no.6 (November/December, 2001), pp. 242–253, available at http://
content.healthaffairs.org/cgi/reprint/20/6/242.pdf.
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Medicare’s per capita spending on disabled beneficiaries is 
somewhat lower than its spending on aged beneficiaries.10 
However, disabled beneficiaries with mental disorders are 
more costly for the Medicare program than the typical dis-
abled beneficiary: Per capita spending on disabled benefi-
ciaries with mental disorders is over 22 percent higher than 
average spending per disabled beneficiary.11 (See Figure 2 for 
Medicare spending on disabled beneficiaries across types of 
mental disorders.)
mental disorders among aged Beneficiaries
Aged beneficiaries are far less likely to exhibit mental dis-
orders than disabled beneficiaries but, because of the size of 
the aged population, most of the Medicare beneficiaries with 
mental disorders are over the age of 65. Prevalence of serious 
mental illness is more equally divided across aged and dis-
abled Medicare beneficiaries. Nearly half of all beneficiaries 
with severe mental illness and about two-thirds of those 
with any form of mental disorder are aged. (See Figure 3 for 
distribution of Medicare beneficiaries with mental disorders.)
Significant cognitive impairments, such as dementia, clearly 
contribute to the prevalence of severe mental illness among 
aged beneficiaries, but the extent to which other severe psy-
chiatric conditions influence disease prevalence has not been
continued on p. 9 
fiGure 3
distribution of medicare  
Beneficiaries with mental disorders,  
by eligibility class
Source: Authors’ calculations based on disease prevalence rates 
cited in this paper and population statistics in CMS, “Medicare 
Enrollment: National Trends—Medicare Aged and Disabled 
Enrollees by Type of Coverage,” 2005; available at www.cms.hhs.
gov/MedicareEnRpts/Downloads/HISMI05.pdf.
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disabled medicare Beneficiaries under 65: 
medicaid eligibility and health care costs, 1995
Source: Sandra M. Foote and Christopher Hogan, “Disability Profile And Health Care Costs Of Medicare 
Beneficiaries Under Age Sixty-Five,” Health Affairs, 20, no.6 (November/December, 2001), pp. 245; 
available at http://content.healthaffairs.org/cgi/reprint/20/6/242.pdf.
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disability, medicare, and medicaid 
Workers who become severely disabled before age 65 and can no longer work are eligible for Social Security 
Disability Insurance (SSDI) payments after five months of unemployment. SSDI recipients are subsequently 
eligible for Medicare coverage after they qualify and receive SSDI benefits for 24 months. Approximately 34 
percent of all such disabled adults with mental disorders are Medicare beneficiaries.
For the Social Security Administration (SSA) “disability” is the inability to work at a job that pays at least 
$900 per month (in 2007) because of a medically determinable physical or mental impairment that is expected 
to result in death or to continue for at least 12 
months. Not all physical and mental conditions 
are included.  For example, drug addiction and 
alcoholism are not qualifying conditions. Fur-
ther, people with serious conditions  meet the 
criteria only after their disease is in an advanced 
stage. Maintaining disability status can be par-
ticularly difficult for mentally ill persons who 
can be stabilized and able to work when they 
are receiving appropriate medical treatment. 
dually eligible — Many low-income ben-
eficiaries who qualify for Medicare due to 
a disability also qualify for Medicaid. Most 
states provide Medicaid coverage for aged, 
blind, and disabled individuals with limited 
income who qualify for Supplemental Security 
Income (SSI) from SSA. There is no wait time 
for SSI eligibility. Approximately 35 percent 
of SSI recipients qualify as a result of a mental 
disorder. Approximately 13 percent of all dis-
abled adults with mental disorders are dually 
eligible for Medicare and Medicaid. Nearly 40 
percent of disabled Medicare beneficiaries with mental disorders are also eligible for Medicaid, compared 
to 30 percent of disabled beneficiaries who do not have a mental disorder.
eligible for medicaid but not medicare — Some disabled people are ineligible for SSDI and Medicare 
because they do not have a sufficient work history but they may be eligible for SSI and Medicaid, depend-
ing on their income level and their state’s eligibility criteria.  This group also includes disabled children 
and people who receive SSDI but have not yet met the two-year waiting requirement for Medicare benefits. 
About 40 percent of all disabled adults with mental disorders are eligible for Medicaid but not Medicare.
eligible for medicare but not medicaid — Disabled persons with a work history who have fulfilled the two 
year wait period will be eligible for Medicare, but some of these individuals will be ineligible for Medicaid 
because their income or assets are too high. Approximately 21 percent of all disabled adults with mental 
disorders are eligible for Medicare but not Medicaid.
ineligible for medicare and medicaid — Some disabled people will not qualify for Medicaid or Medicare. 
This group includes those in the process of fulfilling the two-year waiting period, as well as those who do 
not meet the SSA criteria for disability determination. Approximately 22 percent of disabled adults with 
mental disorders are ineligible for either Medicare or Medicaid.
Source of health insurance coverage 
for persons disabled by mental disorders
Source: Richard G. Frank and Sherry Glied, “Changes In Mental Health 
Financing Since 1971: Implications For Policymakers And Patients,” 
Health Affairs, 25, no.3 (May/June, 2006), p. 606.
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Medicaid
13%
Medicaid
& Medicare
12%
Medicare
                   10%  
Medicare & Private
2%
Other
6%
Uninsured
54% Medicaid 35% Medicare
15%
Private
Background paper
november 27, 2006
national health policy forum  |  www.nhpf.org 9
continued from p. 7
fully documented. Available data suggest that one-quarter to one-half of 
severe mental disorders among the aged are due solely to cognitive limi-
tations. Beneficiaries with dementia may have co-occurring psychiatric 
disorders, such as depression. The prevalence of other serious mental 
disorders, such as schizophrenia, appears to be lower in the aged popula-
tion, most likely because people with these conditions have high rates of 
premature mortality and life-spans that are, on average, 20 years shorter 
than the U.S. average.12
Although access concerns often center on the needs of vulnerable individu-
als with severe mental disorders, mental disorders among aged benefi-
ciaries are more frequently mild to moderate in severity. The three most 
common mental disorders experienced by Medicare beneficiaries over the 
age of 65, in order of prevalence, are anxiety, dementia or other cognitive 
impairments, and depression. The prevalence of dementia doubles every 5 
years beyond age 65, becoming the most common mental health diagnosis 
after age 80.13 The severity of more common disorders, such as dementia, 
can vary considerably, and only a small proportion of those afflicted are 
likely to face significant functional impairments.
While the most common types of mental disorders are not usually severe 
and disabling, people with these mild to moderate mental health diagnoses 
tend to have high rates of other illnesses. The relationship between mental 
health disorders and physical disorders such as diabetes, heart disease, 
and cancer is not fully understood. In some cases, a single disease process 
may be fundamentally responsible for both mental and physical symptoms. 
In other cases, underlying mental disorders may undermine adherence 
to medical protocols (for example, medication management) and healthy 
lifestyle choices, such as diet and exercise, which are known to influence 
the onset and management of other chronic diseases. In still other cases, 
preexisting physical disorders may lead to decreased functionality and 
increased social isolation, which may subsequently trigger mental health 
complications. Left untreated, mild to moderate mental disorders can 
escalate into more serious mental conditions, complicate the treatment of 
physical health conditions, compromise patient outcomes, and increase 
the cost of care. 
medicare policieS related to 
mental health SerViceS
Medicare covers a wide range of mental health services, but special restric-
tions and limitations are often applied to differentiate psychiatric benefits 
from comparable physical health services. The impact of Medicare’s cov-
erage and payment policies on access to mental health services, quality 
of care, and patient outcomes is frequently unclear and sometimes hotly 
debated. The following reviews key issues related to Medicare’s coverage 
of and payment for mental health services.
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inpatient hospital Services
The acute care services needed to diagnose and stabilize individuals in a 
mental health crisis have traditionally been provided in inpatient settings. 
Follow-up treatment planning and referrals for monitoring or additional 
treatment in the community may also begin in an inpatient facility. Care 
is delivered through the combined expertise of multidisciplinary teams 
that include, among others, nurses, psychiatrists, psychologists, and social 
workers. The relative contributions and mix of disciplines appears to vary 
considerably across inpatient settings and geographic areas, depending 
upon care models, patient mix, and workforce characteristics. 
Many mental health experts believe that most 
inpatient psychiatric admissions could be 
avoided if appropriate community-based ser-
vices were utilized properly. However, such 
services are often in short supply or difficult 
to access. The nature of mental disorders can lead patients to delay, resist, 
or refuse necessary treatment until a crisis precipitates intervention. In some 
cases, patients can be hospitalized involuntarily if a court determines that 
their mental illness has resulted in an immediate danger to themselves or 
others. Involuntary hospitalizations typically require admission to a locked, 
secure psychiatric unit. 
life-time limit on inpatient psychiatric services — Under Part A, Medi-
care pays for inpatient psychiatric care provided in both freestanding 
psychiatric hospitals and in dedicated psychiatric units of general acute 
hospitals. These providers are called inpatient psychiatric facilities (IPFs). 
Medicare will also cover inpatient psychiatric services provided in nonspe-
cialized, medical/surgical beds of general hospitals (commonly referred to 
as “scatter beds”). Medicare pays for 100 percent of inpatient psychiatric 
services, subject to a deductible and copayment for extended stays. 
Medicare does not cover long-term custodial care for any condition and 
imposes a 90-day limit on all inpatient hospital coverage for each episode 
of illness (known as a “benefit period,” which begins on the day the ben-
eficiary enters a hospital or skilled nursing facility and ends when the 
beneficiary has been out of the hospital for 60 consecutive days).14 This 
limit applies to both psychiatric and general inpatient services. For general 
hospital services, there are no coverage limits on the total number of benefit 
periods a beneficiary is entitled to in his or her lifetime. However, Medicare 
limits lifetime treatment in freestanding IPFs to 190 days.15 Stays in general 
hospitals for psychiatric services are not subject to the 190-day limit. The 
lifetime psychiatric limit was intended to limit the federal government’s 
role in paying for long-term custodial support of the mentally ill. The limit 
was not imposed on hospital-based units because these facilities have only 
rarely been used for long-term care purposes. 
The extent to which the 190-day limit hinders access to inpatient psychi-
atric services is not clearly understood. Although few beneficiaries reach 
the medicare statute imposes a 190-day life-
time limit on services received in specialty 
psychiatric hospitals.
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the 190-day lifetime limit, the policy is most likely to affect beneficiaries 
disabled by mental illness. These beneficiaries have more frequent psy-
chiatric hospitalizations in a given year and are more likely to be enrolled 
in Medicare for a longer period of time than aged beneficiaries. Although 
beneficiaries who reach the 190-day limit could still be covered for psychi-
atric care provided in general hospitals, consumer advocates and provid-
ers are concerned that the limit may undermine choice of physician and 
jeopardize access to care, particularly in communities where the general 
hospitals lack psychiatric capacity. 
prospective payment — Medicare recently revised its reimbursement 
policy for IPFs, moving in 2005 from a cost-based system, with limits, to a 
per diem prospective payment rate, referred to as the inpatient psychiatric 
facility prospective payment system (IPF-PPS).16 The per diem rate varies, 
depending on the patient’s psychiatric diagnosis-related group—which 
accounts for cost differences across patients that are due to their diagno-
ses, procedures, and other factors—and on whether the patient has any of 
17 coexisting general medical conditions that are associated with higher 
average costs. The per diem rate is higher in the early days of a psychiatric 
stay, in recognition of the costs associated with stabilizing a psychiatric 
patient.17 Care provided in scatter beds is reimbursed under the per case 
hospital inpatient prospective payment system (PPS).
The impact of the IPF-PPS on access to care is uncertain at this time, since it 
is still in its three-year phase-in period. Psychiatric providers are cautiously 
monitoring its effect on a market that has experienced significant fluctuation 
in inpatient psychiatric capacity over the past two decades. Some worry that 
the IPF-PPS may encourage general hospitals (which tend to have higher av-
erage cost structures than freestanding facilities) to further reduce inpatient 
psychiatric capacity in favor of more reliably profitable medical services or 
to shift beds from specialized units to scatter beds, which will not be reim-
bursed under IPF-PPS. In 1995, nearly one-third of all Medicare inpatient 
psychiatric discharges were from scatter beds; this proportion has increased 
as dedicated psychiatric capacity in both freestanding facilities and general 
hospitals has decreased over the last decade. Some experts have expressed 
concerns that the care delivered through scatter beds is not as effective as 
the care delivered in more specialized facilities. Adding to their concern is 
the inability of most scatter beds to accommodate involuntary admissions 
because they lack the security measures required to contain patients who 
have been hospitalized against their will.
Others believe that the payment system may be advantageous to freestand-
ing hospitals that have lower cost structures and more flexibility to target 
services to patient needs. Some believe that, while less efficient providers 
might eliminate psychiatric services, organizations that have developed 
the expertise and economies of scale to deliver psychiatric services in the 
most efficient manner could expand their operations, resulting in little 
overall change in capacity levels.
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partial hospitalization
Partial hospitalization programs, used in lieu of inpatient hospitalizations, 
provide structured, intensive outpatient services. These programs, some-
times referred to as day programs, offer a range of medically appropriate 
services “wrapped around the particular needs of the patient.”18 The services 
generally reflect a multidisciplinary team approach to patient care under 
the direction of a physician and are typically much more intensive than 
those offered through the private practice of an individual mental health 
provider, such as a psychiatrist or psychologist.19 Partial hospitalization 
programs do not provide around-the-clock nursing care, but supervised 
residential facilities may be offered through affiliated organizations. 
Some advocates question the effectiveness of partial hospitalization pro-
grams. The lack of around-the-clock supervision may make these programs 
inappropriate for patients who have not been stabilized. At the same time, 
the institutional nature of these programs hinders the development of 
behavioral skills and coping strategies in a real-world, community-based 
context. Furthermore, partial hospitalization programs often do not include 
the kinds of psychosocial services (such as vocational training and hous-
ing assistance) that are known to support recovery from mental disorders 
because such programs tend to focus solely on clinical services that are 
reimbursable through Medicare and commercial insurers.
regulatory concerns — Partial hospital services were added as an explicit 
Medicare-covered benefit through the Omnibus Budget Reconciliation Act 
of 1987. Previously, mental health services delivered through hospital-
based partial hospitalization programs were sometimes covered as a Part 
A (inpatient) benefit, and freestanding partial hospitalization programs 
were sometimes covered as a Part B (outpatient) benefit, depending on 
the policies of Medicare contractors charged with administering claims.
Partial hospitalization coverage and reimbursement policies have been the 
source of considerable controversy over the past decade. Providers com-
plained that the Centers for Medicare & Medicaid Services (CMS) was slow 
to issue a national review standard when the benefit was first established, 
allowing Medicare contractors to implement variable review procedures 
that limited access in some areas and inadequately regulated services in 
others. After payments to freestanding partial hospitalization programs 
rose sharply between 1993 and 1997, increasing nearly 500 percent (from 
$60 million to $349 million), a series of investigative reports revealed that 
several providers billing for this care delivered care that failed to include 
the mandated set of partial hospitalization services and was not sufficiently 
intensive and therapeutic in nature. 20 Much of this substandard care was 
delivered to patients who did not meet the medical necessity criteria for 
partial hospitalization services. Once apprised of fraud and abuse prob-
lems, CMS intensified scrutiny and decertified many providers across 
the nation. Also, prospective payment for partial hospitalization services, 
implemented in 2000, established a fixed payment amount for the bundle 
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of services offered through the program21 and minimized opportunities 
and incentives for fraud. 
outpatient Services
Outpatient mental health can include a diverse mix of clinical services, 
including diagnostic testing, psychotherapy, targeted case management, 
medication management, and psychosocial services. These services are 
provided by primary care physicians, 
nurse practitioners, and physician assis-
tants, as well as by specialty mental health 
providers, such as psychiatrists, clinical 
psychologists, psychiatric nurse specialists, and social workers. The spe-
cific scope of practice for these professional disciplines is dictated by state 
licensure laws and can vary substantially from state to state.
Medicare Part B pays for professional services delivered in hospital and 
outpatient settings and, since 1989, has allowed billing from a broad range 
of nonphysician mental health service providers subject to state licensing 
parameters.22 However, most mental health services covered by Medicare 
are provided by primary care physicians. More than half (51.6 percent) of 
patients treated for major depression are seen in the general medical sec-
tor and are cared for exclusively by primary care or other nonpsychiatrist 
physicians.23 It is also estimated that 67 percent of psychopharmacological 
drugs are prescribed by primary care physicians.24 
coverage limitations — Medicare has an outpatient mental health limi-
tation that imposes a 50 percent coinsurance on psychotherapy services 
(including individual, family, and group psychotherapy).25 Other mental 
health services (such as inpatient therapy services, diagnostic testing, 
psychological evaluation, and brief visits to monitor the efficacy of pre-
scribed medications) are subject to the standard 20 percent coinsurance.26 
Psychosocial services are generally not covered by Medicare. 
The higher coinsurance level for the most common forms of outpatient 
mental health treatment was originally established to deter inappropriate 
utilization. Policymakers believed that these services were particularly 
vulnerable to overutilization for a variety of reasons, including the nonin-
vasive nature of such services, the lack of objective biomarkers to validate 
diagnoses of mental disorders, and biases regarding the legitimacy of mental 
disorders and mental health treatment.27 Differential cost sharing for mental 
health services was once common practice in commercial insurance prod-
ucts, but many private health insurance plans have moved away from this 
approach as a result of the adoption of more effective, targeted utilization 
management techniques; the enactment of state laws requiring parity for 
mental health coverage; and a growing recognition that untreated mental 
illness can fuel overall health care spending.
The Office of the Inspector General (OIG) within the Department of Health 
and Human Services (DHHS) recently found that Medicare carriers have 
under medicare, outpatient psychotherapy 
services are subject to a 50 percent coinsurance.
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adopted inconsistent policies regarding the application of the limitation, 
which has led to wide geographic variation in beneficiary copayment 
obligations.28 Among the 57 carriers studied, nine different policies for the 
application of the limitation were identified. In over one-half of the service 
areas, carriers subjected evaluation and management services to patients 
with Alzheimer’s disease to the limi-
tation, contrary to federal regulations. 
Although CMS has issued guidance 
related to the limitation, the OIG found 
that this guidance was not sufficiently detailed to ensure uniform imple-
mentation across carriers and recommended that new guidance be issued.
Patient advocates have expressed concern that more onerous cost-sharing 
obligations for outpatient mental health benefits under Medicare discourage 
beneficiaries from seeking necessary services and may significantly limit 
access to treatment for beneficiaries who lack the financial resources or 
supplemental insurance to fulfill the 50 percent coinsurance requirement.29 
The restriction applies only to psychotherapy services but, especially given 
inconsistent policies among carriers, concerns have been raised that both 
patients and providers may believe the higher copayment requirement 
applies to all outpatient mental health services, discouraging use of diag-
nostic and other services not subject to the higher copayment.
Access barriers are perhaps most significant for those dually eligible for 
Medicare and Medicaid.30 While Medicaid is responsible for covering 
the Medicare coinsurance of dual eligibles, state Medicaid programs can 
elect to withhold such payment if the amount paid by Medicare meets or 
exceeds the Medicaid payment rate for that service. Because Medicaid re-
imbursement rates for professional services are generally very low relative 
to Medicare, mental health service providers may be unable to recoup the 
coinsurance payment from either Medicaid or low-income dually eligible 
beneficiaries. Although this dynamic also holds true for outpatient treat-
ment of physical health conditions, the 50 percent effective “discount” on 
mental health providers’ service fees is far more substantial than the 20 
percent “discount” imposed on physical health services.
The Medicare Payment Advisory Committee (MedPAC) has recommend-
ed that the outpatient mental health limitation be eliminated,31 finding 
that the modest increase in program costs likely to result from this action 
($500 million in 2002) is justified in light of the access improvements 
and cost-sharing simplifications that would be achieved. Skeptics ques-
tion whether a more generous outpatient mental health benefit would 
significantly improve appropriate access and worry that inappropriate 
utilization could increase. 
ambiguous billing requirements — The willingness of mental health 
providers to serve Medicare beneficiaries may be further compromised 
by confusion regarding reimbursement policies and practices that result 
in protracted adjudication processes and a high rate of claims denials. Up 
medpac has recommended that the outpatient 
mental health limitation be eliminated.
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to 20 percent of claims for medication management services and up to 50 
percent of claims for group therapy services are denied. Denials are made 
for a variety of reasons, and some proportion of these denials are likely 
valid. The DHHS OIG concluded that one-third of outpatient mental health 
services provided to Medicare beneficiaries were medically unnecessary, 
billed incorrectly, rendered by unqualified providers, or improperly docu-
mented. Group therapy services and psychological testing were found to 
be particularly problematic.32
Many providers believe that local policies 
set by Medicare carriers for outpatient 
mental health services are too vague, too 
narrowly defined, or too often misapplied, 
resulting in inappropriate denial of claims 
or costly resubmissions in order to supply necessary documentation. Provid-
ers complain that mental health services are subject to variable and poorly 
articulated payment rules. Medicare limits coverage to services that are 
medically “reasonable and necessary for the diagnosis or treatment of illness 
or injury or to improve the functioning of a malformed body member.”33 
Relatively few criteria for making specific coverage decisions are set at the 
national level. Rather, Medicare carriers are given a fair degree of latitude 
in establishing rules to assess medical necessity and set service-specific 
requirement to ensure the appropriateness of services. Inconsistency in 
coverage policies across regions is not unique to mental health services, 
but mental health providers believe that the diversity of practices related 
to specialty mental health services adds to the confusion. 
Providers also believe that carriers implement established policies improp-
erly. For example, some carriers have policies stating that psychotherapy 
services for patients with cognitive impairments will not be covered if the 
severity of those cognitive limitations precludes the patient from deriving 
meaningful benefit from the therapy. Approximately 30 percent to 40 per-
cent of people with dementia also have co-occurring mental disorders such 
as depression or psychosis34 that may be helped through psychotherapy, 
but these comorbid disorders often go undiagnosed or undertreated.35 
Providers report that Medicare carriers routinely deny claims for mental 
health services delivered to any individual with dementia, regardless of 
severity level, despite evidence that patients with mild to moderate de-
mentia benefit from psychological interventions that improve functioning 
and coping. Documentation requirements to validate severity level are not 
clearly delineated.
Screening services — Mental health screenings to identify conditions that 
may not be readily apparent to providers are not covered for most exist-
ing Medicare beneficiaries, but a new “Welcome to Medicare,” one-time 
physical examination that includes depression screening is covered for 
any new beneficiary joining the program after January 1, 2005. In general, 
Medicare does not cover preventive health screenings, except for certain, 
statutorily defined services. This initial preventive physical examination 
up to 20 percent of claims for medication 
management services and up to 50 percent of 
claims for group therapy services are denied.
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was added as a benefit by the Medicare Prescription Drug, Improvement 
and Modernization Act of 2003 (MMA) and includes a broad range of 
preventive services. Although depression screening is explicitly identified 
as a component of the physical, Medicare does not require or recommend 
any specific screening tool. 
Primary care physicians believe that many of the standardized, validated 
depression screening tools are too cumbersome to administer during 
a short office visit. The American Academy of Family Physicians has 
advised an approach recommended by the U.S. Preventive Services 
Task Force.36 This approach, the PHQ-2, involves asking two questions: 
“Over the past two weeks, have you felt down, depressed or hopeless?” 
and “Over the past two weeks, have you felt little interest or pleasure in 
doing things?” Answers can either be yes/no or scaled from zero (not at 
all) to three (nearly every day). An affirmative answer to either question 
should prompt seven additional questions that provide more detailed 
evaluation for depression. The extent to which the “Welcome” physi-
cal in general and the depression screen in particular will be used is as 
yet unclear. Patient advocates have raised concerns that even if these 
screenings are helpful for new beneficiaries, coverage is not available for 
either screening beneficiaries enrolled before January 2005 or conducting 
periodic reassessments. 
psychiatric practice incentives — Psychiatrists have increasingly discon-
tinued offering psychotherapy as a component of their practice, prefer-
ring to focus on more lucrative medication management services. The 
financial incentives established by Medicare and other payers encourage 
psychiatrists to provide psychopharmacologic treatments in contrast to 
psychotherapy. Reimbursement rates show a clear economic advantage 
to providing medication with brief follow-up visits and a clear financial 
disincentive to provide psychotherapy37. Psychiatrists earn about $100 less 
an hour for providing one 45- to 50-minute session of psychotherapy than 
for providing three medication management visits in the same time. Some 
private managed care organizations expressly prohibit psychiatrists from 
providing psychotherapy. Inadequate psychotherapy training in some 
psychiatric residency programs appears to reinforce the trend away from 
psychotherapeutic approaches. These forces have made the delegation 
of psychotherapy services—if they are offered at all—to nonphysician 
providers common practice, with little coordination between therapists 
and prescribing physicians.
Many worry that this practice of “splitting” treatment has a negative 
impact on the quality of patient care and patient outcomes. Opinions dif-
fer as to the best way to resolve this problem. Some would advocate for 
psychiatrists to increase their involvement in providing psychotherapy. 
Others believe that the delegation of psychotherapy to less highly com-
pensated, yet qualified, professionals is economically efficient and desir-
able but worry that these providers are not properly trained to monitor 
prescription drug use. Still others advocate giving limited prescription 
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privileges to psychologists. Some would argue that more should be done 
to build a team approach to service delivery.
reimbursement of nonphysician providers — The central role of non-
physician providers in delivering psychotherapy suggests that these are 
the providers most likely to be influenced by Medicare’s outpatient mental 
health limitation. For many of them, the financial disincentives of the higher 
copayment level are compounded by other reimbursement policies that 
decrease their payment levels relative to those of physicians. Nonphysician 
providers recognized by Medicare receive different rates for their services. 
For example, psychologists are paid 100 percent of the physician fee sched-
ule, whereas social workers receive 75 percent of the physician rate. In 
addition to psychologists and social 
workers, Medicare also makes direct 
payment to nurse practitioners with 
the equivalent of a master’s degree 
in psychotherapy and to clinical 
psychiatric nurse specialists. Other 
types of mental health service pro-
viders, such as licensed professional clinical counselors and marriage and 
family therapists, can only be paid indirectly by Medicare (for example, 
through a physician who employs, supervises, and pays them) and only in 
limited circumstances. 
It has been argued that expanding the number of professional disciplines 
approved for direct payment from Medicare and raising the payment 
rates for professions paid below the physician fee schedule could improve 
access to mental health services, particularly in rural areas with health 
provider shortages. However, MedPAC recently recommended against 
such expansions, finding that, although utilization would probably rise, 
the increase in program costs likely to result from this action would not 
represent a prudent use of resources. 
prescription drugs 
Psychotropic drugs, broadly defined, include any chemical substance that 
alters brain function. Psychotropic medications commonly used to treat 
mental disorders include antidepressants, antipsychotics, antianxiety 
agents, and stimulants. Increasingly a central component in the treatment 
of mental illness, such drugs were used in 75 percent of mental health 
treatment cases in 2001.38 Pharmacological interventions are most effective 
when delivered in combination with psychotherapy.39 However, for nearly 
half of all patients taking psychotropic drugs, medication is the only form 
of treatment received.40 
Psychotropic medications can be particularly complicated to monitor, and 
establishing effective treatment regimens for vulnerable patients with co-
occurring neurological disorders is complex. Individuals with severe men-
tal impairments may resist changing medications because treatment often 
although pharmacological interventions are most 
effective when delivered in combination with psy-
chotherapy, nearly half of all patients taking psy-
chotropic drugs receive no other  form of treatment.
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requires considerable trial and 
error before an effective medica-
tion or medication combination 
can be identified. Disruptions in 
medications can be dangerous 
for these individuals, resulting 
in rapid deterioration, impaired 
functioning, increased health care 
utilization, and overuse of more 
expensive urgent care services 
and inpatient hospitalizations.
Medicare Part D began cover-
ing outpatient prescription psy-
chotropic and other drugs in 
January 2006. Coverage is pro-
vided through either private, 
stand-alone prescription drug 
plans or drug plans offered by 
Medicare Advantage managed 
care plans (both types referred 
to here as “drug plans.”) In 
general, individual plans have 
a great deal of latitude in de-
termining which drugs are 
included on a plan’s formulary 
and cost-sharing requirements, 
but the formulary and benefit design must be approved by CMS. Benefi-
ciaries can select from the drug plans available in their geographic region. 
Dually eligible enrollees were automatically enrolled in drug plans in 
an attempt to avoid gaps in coverage as these beneficiaries transitioned 
from Medicaid to Part D coverage. 
protections — CMS recognized that private health plans would have some 
incentive to discourage enrollment by high-risk, costly populations, includ-
ing those with mental illness, and implemented protections to minimize risk 
selection. Beneficiaries with a mental disorder have high per capita drug 
expenditures,41 spending, on average, 61 percent more on drugs than ben-
eficiaries without mental illness.42 (See Figure 4 for average drug spending 
among Medicare beneficiaries.) In order to minimize the development of 
benefit designs and enrollment strategies biased against such high-cost 
patients, CMS required drug plans to conform to a variety of safeguards.
n	protected drug classes. Plans are required to cover “all or substantially 
all” drugs available in six special classes: antidepressants, antipsy-
chotics, anticonvulsants, antineoplastics, antiretrovirals, and immune 
suppressants.43 These drug classes are essential to vulnerable groups 
known to have high prescription drug costs, such as people with mental 
illness, HIV/AIDS, and cancer. 
fiGure 4
average annual drug Spending among medicare Beneficiaries
Source: Adapted from exhibit 5 in Julie Donohue, “Mental Health In The Medicare Part D Drug Benefit: 
A New Regulatory Model?” Health Affairs, 25, no. 3 (May/June 2006), p. 711.
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n	Utilization management. Drug plans are precluded from imposing 
utilization management (such as prior authorization, quantity limits, 
and step therapy) on individuals who were stabilized on drugs in 
protected drug classes before being enrolled in the drug plan.44 Plans 
must also continue coverage for protected medications during the 
annual benefit period, even if the medication is removed from the 
formulary. However, plans can apply utilization management tools on 
any prescription initiated after enrollment in the plan (such as new or 
different medications or dosage changes). It is not clear how long these 
protections will remain in place, and plans are not required to provide 
all doses and forms of a medication (for example, continuous release 
formulations), which can be particularly problematic for psychotropics 
because many are prescribed “off-label” at dosage levels that have not 
been evaluated by the Food and Drug Administration.45
n	Cost sharing. Plans have flexibility in determining placement of drugs 
on cost-sharing tiers within the formulary. However, plans are explicitly 
prohibited from using their formularies to discriminate against any 
class of beneficiaries, and CMS has reviewed drug plans’ cost-sharing 
requirements to ensure that protected drug classes are not systemati-
cally assigned to the highest cost-sharing tiers.
“Benzos” exclusion — Although Part D mandates coverage for many 
of the psychotropic drugs used to treat mental illness, some types of 
psychotropic drugs (such as antidementia medications) are not in a 
protected class, and benzodiazepines are statutorily excluded from 
coverage. Benzodiazepines, 
which are tranquilizing agents, 
have been the subject of contro-
versy for several decades. These 
medications can lead to depen-
dency, and drug-related adverse 
events (such as oversedation, 
falls, and hip fractures) may be 
more common in older patients 
taking this drug. Nonetheless, 
benzodiazepines continue to 
be widely used today, and a 
growing clinical consensus has 
developed around their appro-
priate use. (See Table 1 for an 
overview of psychotropic drug 
use by therapeutic category and 
eligibility class.) Abrupt termi-
nation of benzodiazepines can 
lead to severe withdrawal reac-
tions.46 In large part because of 
these clinical concerns, all state 
taBle 1
Percentage of Medicare Beneficiaries Using Psychotropic Drugs 
by therapeutic Category and eligibility, 2002
	
	 	DisableD	 ageD
	 Dually	 	 Dually
	 eligible	 Other	 eligible	 Other
 any Psychotropic Drug Use 53.1% 47.8% 31.0% 22.6%
 
 Antidepressants 39.8% 38.1% 20.6% 15.9%
 Antipsychotics 22.6 8.6 5.0 1.4
 Antimanics 16.3 12.9 4.5 2.3
 Dementia Drugs 0.1 0.4 3.4 2.2
 Benzodiazepines 10.7 11.7 9.0 6.6
 Barbiturates 0.5 0.4 0.2 0.1
*Percentages of use in therapeutic categories will exceed drug use total because some beneficiaries use 
multiple categories of drug.
Source: Adapted from exhibit 2 in Julie Donohue, “Mental Health In The Medicare Part D Drug Benefit: 
A New Regulatory Model?” Health Affairs, 25, no. 3 (May/June 2006), p. 710.
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Medicaid programs have historically provided some level of coverage 
for benzodiazepines, despite the fact that the Medicaid statute allows 
states to exclude coverage of these drugs at their discretion.
transitions from medicaid to medicare — Advocates have raised con-
cerns about how coverage changes could affect the more than 6 million 
beneficiaries who are dually eligible for Medicaid and Medicare, 39 percent 
of whom have mental disorders. Access to psychotropic drugs is likely to 
improve for many Medicare beneficiaries who did not have prescription 
drug coverage before the implementation of Part D but, for dually eligible 
people, the transition could be problematic. Enrollment in Part D was 
mandatory for the dual eligibles who had received drug coverage through 
state Medicaid programs before 2006. Duals in some states may encounter 
new formulary rules and higher cost-sharing requirements. Some Medicaid 
programs exempt psychotropics from utilization management restrictions, 
and pharmacists are legally required to fill prescriptions, regardless of the 
individual’s ability to pay the copayment amount. Sources of drug spend-
ing for Medicare beneficiaries are shown in Figure 5.
Under Medicare Part D, dual eligibles will continue to be exempt from 
paying premiums or deductibles (as they were under Medicaid) if they are 
enrolled in below-average premium plans. However, they are responsible 
for low copayments ($1 for generic drugs and $3 for brand name drugs, 
depending upon their income) and pharmacists are now able to require co-
payments before filling prescriptions. Studies have shown 
that even small copays can significantly lower utilization 
of prescription drugs among low-income populations.47 
These copayments, though seemingly small, can be a sig-
nificant burden for duals with multiple chronic conditions 
who struggle to cover costs of several medications with 
SSDI or Social Security subsidies that are often inadequate 
to cover housing and food costs.48
risk adjustment — Federal payments to drug plans are 
intended to minimize the disincentives associated with 
enrolling high-cost patients, such as those with mental 
disorders, by (i) tying payment level to the risk associated 
with individual enrollees and (ii) limiting the collective 
risk incurred by plans through the use of risk corridors 
and reinsurance payments for larger-than-expected cata-
strophic expenses. A new risk adjustment model designed 
for Part D adjusts payments based on age and specific 
comorbidities. The risk adjuster accounts for 23 percent 
of the variation in drug spending. Although the Part D 
risk adjuster appears to offer an improvement over older 
risk adjustment models and is considered to offer fairly 
generous protection, the extent to which it obviates risk 
selection incentives is not yet clear. Patient advocates worry 
fiGure 5
Sources of prescription drug Spending 
for medicare Beneficiaries, 2002
Source: Adapted from exhibits 3 and 4 in Julie Donohue, “Mental Health 
In The Medicare Part D Drug Benefit: A New Regulatory Model?” 
Health Affairs, 25, no. 3 (May/June 2006), p. 712. 
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that plans may still have financial incentives to use aggressive utiliza-
tion management tools and pricing practices to discourage enrollment 
by persons with mental illness.49 
care management
Efforts to improve the management and integration of the multiple mental 
health services covered under Medicare are limited. Medicare’s struggle to 
coordinate care and control costs under a largely fee-for-service program 
lacking robust utilization management mechanisms has led Congress to 
explore the utility of private market disease management programs, which 
focus on coaching patients, rather than attempting to influence provider 
practices directly. The recent Medicare Health Support program autho-
rized by the MMA pays participating disease management vendors and 
insurance plans a monthly per beneficiary fee for managing a population 
of chronically ill beneficiaries. 
To date, no disease management effort has focused on a mental disorder, 
and few have incorporated mental health screening and care coordination to 
address the impact of mental comorbidities on physical conditions like dia-
betes. Given the prevalence of mental disorders in the Medicare population 
and the association of mental disorders with higher health care spending, a 
strengthened emphasis on mental health could prove useful.
Medicare managed care plans do not appear to have made great strides 
beyond the fee-for-service program. Mental health benefits, care man-
agement techniques, and outcomes have not been rigorously studied in 
Medicare managed care plans. Available evidence suggests that Medicare 
+Choice (now Medicare Advantage) plans provide poorer quality mental 
health services than employer-sponsored managed care plans.50 In only 
one area—mental health—do Medicare managed care plans score lower 
than their employer-sponsored counterparts on quality of care measures. 
Fewer Medicare beneficiaries receive appropriate follow-up after hospi-
talization for a mental illness and fewer receive appropriate management 
of their antidepressant medications. These findings suggest that Medicare 
managed care plans have not taken steps to optimize use of appropriate 
mental health services and have likely modeled their benefits on the ex-
isting fee-for-service structure. This is not surprising, as more generous 
benefits relative to the traditional program could lead to adverse risk selec-
tion for the plans, which have no incentive to attract high-need patients 
with mental disorders.
Managing care for beneficiaries with severe mental illnesses is especially 
challenging because these patients need psychosocial, rehabilitative, and 
supportive services that are not typically covered through traditional insur-
ance programs outside of Medicaid. Such services recognize that the nature 
of mental illness interferes with treatment compliance and assists people 
at various stages of the recovery process to reduce distress and prevent 
relapse or rehospitalization. Studies have shown psychosocial models to be 
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more effective at identifying and delivering mental treatment, improving 
activities of daily living, and reducing utilization of inpatient and other, 
nonpsychiatric health care services.51 The addition of these services, while 
cost-effective in terms of the outcome improvements achieved, may not be 
cost-saving. Therefore, it will be difficult for managed care organizations 
to implement evidence-based practices if the costs of psychosocial support 
services are not factored into their capitation rates.
While dual eligibles have some access to rehabilitative and psychosocial 
services through Medicaid and local state agencies, care management for 
these beneficiaries is complicated by the complexity of coordinating cover-
age and payment policies across Medicare and Medicaid. A recent MedPAC 
report identified a number of conflicts, inconsistencies, or unclear policies 
that have the potential to hinder care delivery for dual eligibles.52 MedPAC 
recommended that many of these coverage and payment issues could be 
alleviated if dual eligibles were enrolled in the same plan for both Medicare- 
and Medicaid-covered services and the plan took steps to integrate benefits. 
This integration has occurred in 
demonstration projects, such as 
the Program of All-Inclusive 
Care for the Elderly (PACE) 
and the Wisconsin Partnership 
Program. However, the cost-
effectiveness of these plans has not been well established and they serve 
only a small fraction of dual eligibles. 
Medicare Advantage Special Needs Plans (SNPs), authorized by the MMA, 
offer another potential avenue to better manage care for Medicare benefi-
ciaries with mental disorders, but a SNP focused on this population has 
not yet been developed. SNPs provide an opportunity to integrate acute 
and long-term care services and increase coordination of Medicare and 
Medicaid financing and benefit structures. These plans are subject to the 
same rules and requirements as other Medicare Advantage plans but they 
are able to provide products focused exclusively on specialized popula-
tions, such as the dual eligibles, the institutionalized, and other chronically 
ill populations. SNPs may limit enrollment to one of the special needs 
populations, tailoring benefits and provider networks to best meet the 
needs of these vulnerable groups. Concerns have been raised that SNPs 
are not required to coordinate with state Medicaid programs and may do 
little to integrate care for vulnerable populations.
medicare SpendinG 
for mental health SerViceS
Medicare expenditures for mental health services reflect the program’s 
benefit design. Before the introduction of Part D, Medicare spending on 
mental health accounted for a relatively small proportion of total mental 
health expenditures and an even smaller proportion of total Medicare 
a recent medpac report identified a number of con-
flicts, inconsistencies, or unclear policies that have 
the potential to hinder care delivery for dual eligibles.
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spending. Medicare spending on all mental health 
services in 2001 was $7.2 billion, representing 3 
percent of all Medicare spending ($242 billion). 
In contrast, mental health as a proportion of all 
health care expenditures accounted for 12 percent 
of Medicaid funds and 4 percent of spending by 
private insurance in 2001.53 Mental health spend-
ing across payers is presented in Figure 6.
The limited nature of Medicare’s mental health 
benefits has shielded the program from the 
mental health costs of its beneficiaries. Al-
though roughly 20 percent of all persons with 
mental disorders are covered by Medicare,54 
the program contributes only 7 percent of total 
spending on mental health services. This dis-
proportionately low funding rate is attributed 
to the absence of a prescription drug benefit 
prior to 2006, limited coverage for outpatient 
services, and other benefit design features that 
may decrease covered spending and limit ser-
vice utilization for mental health services.
Total mental health spending by Medicare ben-
eficiaries55 has historically been heavily skewed 
toward inpatient services, with 56 percent of 
the total going to inpatient care and only 30 percent toward outpatient 
services. This relationship is in contrast to national trends showing a re-
versal in inpatient and outpatient spending over the past decade, during 
which inpatient spending declined from 40 percent to 24 percent while 
outpatient spending increased from 36 percent to 50 percent of all mental 
health spending.56
Medicare’s mental health costs, while small relative to those of other pay-
ers, have been rising rapidly in recent years. The growth rate for Medicare 
spending on mental health services increased from 3 percent to 7 percent 
over the past decade, making it second only to Medicaid’s. This growth is 
attributed to the rising number of Medicare beneficiaries who qualify for 
the program as the result of a mental health disability.57 
With the advent of Part D, the growth of mental health spending under 
Medicare will accelerate significantly. Medicaid spending on psychotropic 
medications for dually eligible beneficiaries totaled more than $6.3 billion 
in 2002—an amount almost equal to total mental health expenditures by 
Medicare in 2001. This suggests that Medicare spending for mental health 
services will at least double as a result of Part D. Spending increases will 
likely be even higher in light of psychotropic drug expenditures associ-
ated with non–dual eligibles and apparent increases in psychotropic drug 
prices relative to those paid by state Medicaid programs. Because these 
fiGure 6
mental health Spending by payer class, 2001
Source: Tami L. Mark et al.,”U.S. Spending For Mental Health And Substance 
Abuse Treatment, 1991–2001,” Health Affairs Web Exclusive (March 29 2005), 
p. W5-137.
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drugs were in a protected class, drug plans contend that they had little 
leverage to negotiate price on these products with manufacturers. Plans 
were mandated to cover a broad range of products in protected classes 
and, therefore, had little latitude to offer volume guarantees in exchange 
for price discounts.
Although prescription drug costs have not been a significant cost factor for 
Medicare until recently, it is important to note that psychotropic medications 
account for almost all growth in mental health spending for other public 
and private insurance plans over the last 15 years. In 1987, 7.7 percent of 
all mental health care spending in the United States was for psychotropic 
medications. By 2001, spending on psychotropic drugs accounted for 21 
percent of total mental health spending.58 Between 1992 and 1997, total 
U.S. spending on psychotropic drugs grew at twice the rate of total drug 
spending and, since 1997, spending growth for psychotropic medications 
has outpaced both total health care spending and total drug spending.59 
In 2003, more than $18 billion was spent on antidepressant and antipsy-
chotic drugs.60 Figure 7 displays growth in psychotropic drug spending 
as percentage of total mental health spending.
concluSion
A dramatic increase in spending for mental health services under Medicare, 
resulting largely from the introduction of the prescription drug benefit, 
has the potential to trigger a much broader assessment of the program’s 
mental health policies. As Medicare expenditures for mental health begin 
to more accurately reflect the burden of disease borne by beneficiaries, 
policymakers may take a much closer look at the value of the services being 
purchased. The conclusions they reach could well hinge on an assessment 
of the effectiveness and efficiency of the services delivered, along with an 
exploration of the extent to which financing incentives are contributing 
to these clinical practices: Are the “right” mental health services being 
delivered to the “right” Medicare beneficiaries at the “right” time at the 
“right” price?
While the same questions could be posed for any service covered by 
Medicare, mental health services have often been singled out for special 
consideration, and the influence of these “exceptional” policies is unclear. 
Medicare and other insurers have often treated mental health services 
differently from other services because mental health care can differ sig-
nificantly from the traditional medical model. Medicare’s mental health 
policies are often debated in a piecemeal, disjointed fashion, frequently 
as footnotes to more global policy changes. There may be some benefit to 
considering Medicare’s mental health policies more holistically in order 
to better consider how these policies interact and reinforce (or contradict) 
each other.
In monitoring protections developed under Part D to prevent discrimination 
against persons with mental illness and other costly conditions, policymakers 
fiGure 7
psychotropic drug 
expenses as a percentage  
of overall mental health 
Spending, 1987–2001
Source: Richard G. Frank, Rena M. Conti, 
and Howard H. Goldman, “Mental Health 
Policy and Psychotropic Drugs,” Mil-
bank Quarterly, 83, no. 2 (2005), pp. 
271–296; available at www.macfound.
org/atf/cf/%7bb0386ce3-8b29-4162-8098-
e466fb856794%7d/mental%20health% 
20ftf%203%2006.pdf.
1987 1992 1997 2001
7.7%
7.2%
12.8%
21.0%
Background paper
november 27, 2006
national health policy forum  |  www.nhpf.org 25
may find it necessary to consider how policies related to other services are 
influencing psychotropic drug utilization. Assessing the impact of restric-
tions on outpatient mental health services, tracking the influence of prospec-
tive payment on inpatient psychiatric capacity, exploring mechanisms to 
better leverage Special Needs Plans and other care management strategies, 
and examining eligibility policies for disabled persons are among the issues 
that may come under further scrutiny as Medicare’s spending on those with 
mental disorders continues to rise. 
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